APP and Alzheimer disease: The increased markers of oxidative stress in AD and MCI have been shown to be associated with amyloid β-peptide (Aβ), a 40 to 42 amino acid residue neurotoxic peptide, that is derived from the proteolytic cleavage of amyloid precursor protein (APP), by the action of beta- and gamma-secretase [31].